Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 15,709 | 16,661 | 17,576 | 22,728 | 22,124 |
| Gross Profit | 15,709 | 16,661 | 17,576 | 22,728 | 22,124 |
| Operating Expenses | 10,761 | 11,156 | 10,730 | 61,671 | 10,657 |
| Operating Income | 4,948 | 5,505 | 6,846 | -38,943 | 11,467 |
| Interest Expense | 992 | 1,050 | 1,302 | 2,808 | 2,435 |
| Other Income | 1 | 3 | 4 | 21 | 38 |
| Pre-tax Income | 3,957 | 4,458 | 5,548 | -41,730 | 9,070 |
| Income Tax | 763 | 1,125 | 1,593 | 2,665 | 3,181 |
| Net Income Continuous | 3,194 | 3,333 | 3,955 | -44,395 | 5,889 |
| Net Income | $3,194 | $3,333 | $3,955 | $-44,395 | $5,889 |
| EPS Basic Total Ops | 0.18 | 0.19 | 0.22 | -2.57 | 0.34 |
| EPS Basic Continuous Ops | 0.18 | 0.19 | 0.22 | -2.56 | 0.34 |
| EPS Diluted Total Ops | 0.18 | 0.19 | 0.22 | -2.57 | 0.34 |
| EPS Diluted Continuous Ops | 0.18 | 0.19 | 0.22 | -2.56 | 0.34 |
| EBITDA(a) | $9,792 | $10,305 | $11,802 | $16,488 | $16,546 |